...
首页> 外文期刊>Journal of Clinical Oncology >Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection.
【24h】

Complete remission of primary high-grade B-cell gastric lymphoma after cure of Helicobacter pylori infection.

机译:幽门螺杆菌感染治愈后,原发性高级B细胞胃淋巴瘤完全缓解。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: Treatment of low-grade gastric mucosa-associated lymphoid tissue lymphoma by eradication of Helicobacter pylori is reported to result in complete lymphoma remission in approximately 75% of cases. The effect that cure of the infection has on the course of a primary high-grade gastric lymphoma is largely uncertain. The aim of this study was to report the effect of cure of H pylori infection exerted in patients with high-grade B-cell gastric lymphoma. PATIENTS AND METHODS: Eight patients (4 males and 4 females; age range, 26 to 85 years) with H pylori infection and high-grade lymphoma received eradication therapy before planned treatment. The effect of H pylori eradication on the course of high-grade lymphoma was assessed by analysis of surgical specimens (n = 2) or endoscopic biopsies (n = 6). RESULTS: H pylori eradication was successful in all patients and led to complete remission of the lymphoma in seven patients. One patient has experienced partial remission. Two patients were referred to surgery, one of whom (stage II(1E)) had lymph node involvement, and the histologic work-up of the resected stomach revealed residual infiltrates of a low-grade lymphoma, which prompted consolidation chemotherapy. In one patient (initially stage I(1E)), abdominal lymphoma developed 6 months after eradication therapy, which regressed completely after chemotherapy. In four patients, no further treatment was given. Six patients continue in complete remission (range, 6 to 66 months). CONCLUSION: Primary high-grade B-cell gastric lymphoma in stages I(E) through II(E1) associated with H pylori may regress completely after successful cure of the infection. Prospective trials are needed to investigate this treatment in larger numbers of patients.
机译:目的:据报道,通过根除幽门螺杆菌治疗低级胃黏膜相关淋巴组织淋巴瘤可导致约75%的病例完全缓解。感染治愈对原发性高级别胃淋巴瘤病程的影响尚不确定。这项研究的目的是报告治愈幽门螺杆菌感染对高级别B细胞胃淋巴瘤患者的疗效。患者和方法:8例幽门螺杆菌感染和高级别淋巴瘤患者(4例男性和4例女性;年龄在26至85岁之间)接受了根治性治疗,然后进行了计划的治疗。通过分析手术标本(n = 2)或内窥镜活检(n = 6)来评估幽门螺杆菌根除对高级别淋巴瘤病程的影响。结果:所有患者均成功根除幽门螺杆菌,导致7例淋巴瘤完全缓解。一名患者出现部分缓解。 2例患者被转介手术,其中1例(II(1E)期)受累于淋巴结,切除的胃组织学检查显示低级淋巴瘤残留浸润,提示巩固化疗。在一名患者(最初为I(1E)期)中,根除性治疗6个月后出现腹腔淋巴瘤,化疗后完全消退。在四名患者中,没有进一步的治疗。六名患者继续完全缓解(范围为6到66个月)。结论:成功治愈感染后,与幽门螺杆菌相关的I(E)至II(E1)期原发性高级别B细胞胃淋巴瘤可能会完全消退。需要进行前瞻性试验来研究更多患者的这种治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号